59 Eradication of community-onset MRSA carriage 3 74. Petersen IS, Christensen JM, Zeuthen AB, Madsen PB. Danish experience of meticillinresistant Staphylococcus aureus eradication with emphasis on nose- throat colonization and supplementary systemic antibiotic treatment. J Hosp Infect 2019;103:461e4. 75. Bagge K, Benfield T, Westh H, Bartels MD. Eradicating MRSA carriage: the impact of throat carriage and Panton-Valentine leukocidin genes on success rates. Eur J Clin Microbiol Infect Dis 2019;38:683e8. 76. Piewngam P, Khongthong S, Roekngam N, Theapparat Y, Sunpaweravong S, Faroongsarng D, et al. Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo- controlled trial. Lancet Microbe 2023;4:e75e83. 77. Kaspar U, de Haro Sautto JA, Molinaro S, Peters G, Idelevich EA, Becker K. The novel phage-derived antimicrobial agent HY-133 is active against livestock- associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2018;62:e00385-18. 78. Yendewa GA, Griffiss JM, Jacobs MR, Fulton SA, O’Riordan MA, Gray WA, et al. A twopart phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: a previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation. J Glob Antimicrob Resist 2020;21:171e80. 79. Nibbering PH, Go€blyo€s A, Adriaans AE, Cordfunke RA, Ravensbergen B, Rietveld MH, et al. Eradication of meticillin-resistant Staphylococcus aureus from human skin by the novel LL-37-derived peptide P10 in four pharmaceutical ointments. Int J Antimicrob Agents 2019;54:610e8. 80. de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 2018;10:eaat5731. 81. Clegg J, Soldaini E, McLoughlin RM, Rittenhouse S, Bagnoli F, Phogat S. Staphylococcus aureus vaccine research and development: the past, present and future, including novel therapeutic strategies. Front Immunol 2021;12: 705360.
RkJQdWJsaXNoZXIy MTk4NDMw